“By integrating Oxford Nanopore’s direct RNA sequencing into Lonza’s QC environment, we are enabling a more comprehensive and scalable approach to mRNA quality control,” said Francis Van Parys, CEO, Oxford Nanopore Technologies
May 20, 2026